About this document
SERETIDE DISKUS COPD Treatment Update by Dorina Claudia Dumitrana is a document available to read on EtoBox.
The document is an opinion from the Transparency Committee regarding the modification of the indication for SERETIDE DISKUS 500/50 micrograms/dose for treating COPD patients with an FEV1 of less than 60%. The request is based on the TORCH study, which found no significant improvement in all-cause mortality with the combination therapy compared to placebo, although it showed a reduction in moderate-to-severe exacerbations. The document highlights the increased risk of pneumonia associated with the treatment,
- Author
- Dorina Claudia Dumitrana
- Language
- EN